These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30916801)

  • 1. The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.
    Tracy SI; Larson MC; Feldman AL; Maurer MJ; Novak AJ; Slager SL; Villasboas JC; Allmer C; Habermann TM; Farooq U; Syrbu S; Cerhan JR; Link BK
    Am J Hematol; 2019 Jun; 94(6):658-666. PubMed ID: 30916801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Marginal Zone Lymphoma International Prognostic Index.
    Hong J; Cho J; Ko YH; Kim SJ; Kim WS
    Ann Hematol; 2019 Feb; 98(2):457-464. PubMed ID: 30310985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
    Troch M; Wöhrer S; Raderer M
    Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.
    Kim HD; Cho H; Jeong H; Bang K; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Oh SY; Suh C
    Br J Haematol; 2021 Apr; 193(2):307-315. PubMed ID: 33216979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
    Maurer MJ; Bachy E; Ghesquières H; Ansell SM; Nowakowski GS; Thompson CA; Inwards DJ; Allmer C; Chassagne-Clément C; Nicolas-Virelizier E; Sebban C; Lebras L; Sarkozy C; Macon WR; Feldman AL; Syrbu SI; Traverse-Glehan A; Coiffier B; Slager SL; Weiner GJ; Witzig TE; Habermann TM; Salles G; Cerhan JR; Link BK
    Am J Hematol; 2016 Nov; 91(11):1096-1101. PubMed ID: 27465588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
    Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A;
    Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A MALT lymphoma prognostic index.
    Thieblemont C; Cascione L; Conconi A; Kiesewetter B; Raderer M; Gaidano G; Martelli M; Laszlo D; Coiffier B; Lopez Guillermo A; Torri V; Cavalli F; Johnson PW; Zucca E
    Blood; 2017 Sep; 130(12):1409-1417. PubMed ID: 28720586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
    Xu X; Wang Z; Yu Y; Wang Y; Zhang L; Sun B; Da W; Zhang Y
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1678-84. PubMed ID: 24730769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
    Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
    Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas.
    Demirdas S; Hense J; Dührsen U; Hüttmann A
    Oncol Res Treat; 2019; 42(11):580-588. PubMed ID: 31536987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
    Alderuccio JP; Zhao W; Desai A; Ramdial J; Gallastegui N; Kimble E; de la Fuente MI; Husnain M; Rosenblatt JD; Alencar AJ; Schatz JH; Moskowitz CH; Chapman JR; Vega F; Reis IM; Lossos IS
    Am J Hematol; 2019 May; 94(5):585-596. PubMed ID: 30784098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
    Luminari S; Merli M; Rattotti S; Tarantino V; Marcheselli L; Cavallo F; Varettoni M; Bianchi B; Merli F; Tedeschi A; Cabras G; Re F; Visco C; Torresan Delamain M; Cencini E; Spina M; Ferrero S; Ferrari A; Deodato M; Mannina D; Annibali O; Rago A; Orsucci L; Defrancesco I; Frigeni M; Cesaretti M; Arcaini L
    Blood; 2019 Sep; 134(10):798-801. PubMed ID: 31292118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
    Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
    Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Singh AD; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 May; 173(3):404-12. PubMed ID: 26953041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.